| 证券代码 | PBIO.O |
| 证券名称 | Pressure BioSciences Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | - |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | - |
| 公司名称 | Pressure BioSciences, Inc. |
| 注册地址 | 美国马萨诸塞州 |
| 办公地址 | 14 Norfolk Avenue, South Easton, Massachusetts, USA |
| 成立日期 | 1978-08 |
| 董事会主席 | Jeffrey N. Peterson |
| 公司属地 | United States 美国 |
| 公司网址 | www.pressurebiosciences.com |
| 电话 | +1 (508) 230-1828 |
| 传真 | +1 (508) 230-1829 |
| 公司简介 | Pressure BioSciences, Inc. develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Their products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. |